<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01239303</url>
  </required_header>
  <id_info>
    <org_study_id>MEC10-3-064</org_study_id>
    <nct_id>NCT01239303</nct_id>
  </id_info>
  <brief_title>Effects of Citrulline on Gut Functioning During Excercise</brief_title>
  <official_title>Effects of Citrulline on Gut Functioning During Excercise</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Top Institute Food and Nutrition</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      During exercise, splanchnic perfusion is compromised, resulting in organ damage in healthy
      individuals. Improving the availability of NO might result increase splanchnic perfusion and
      prevent organ damage during exercise.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The gastrointestinal (GI) tract plays an important role in the human body. The wall of the GI
      system regulates digestion and absorption of nutrients and it also has a very important
      function as a barrier between internal and external environment. The penetration of harmful
      substances and microbiota of the GI lumen (external environment) to the systemic circulation
      (internal environment) depends on this barrier. Previous studies have shown that exercise in
      healthy subjects provides hypoperfusion of the splanchnic area, resulting in intestinal
      damage, increased small intestinal permeability and liver damage. Similar splanchnic
      hypoperfusion occurs in patients with compromised circulation.

      During episodes of splanchnic hypoperfusion, the de novo synthesis of nitric oxide (nitric
      oxide, NO) from arginine is compromised. This impaired NO synthesis may play a role in the
      development of organ dysfunction during exercise. L-citrulline administration, a precursor of
      arginine and NO, may result in improved NO availability and organ perfusion, thereby
      preventing organ damage.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>December 2010</start_date>
  <completion_date type="Anticipated">February 2012</completion_date>
  <primary_completion_date type="Anticipated">January 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>GI perfusion</measure>
    <time_frame>2 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>gut damage</measure>
    <time_frame>5 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>microcirculation</measure>
    <time_frame>5 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>liver damage</measure>
    <time_frame>5 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>kidney damage</measure>
    <time_frame>5 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>amino acid analysis</measure>
    <time_frame>5 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Gastrointestinal</condition>
  <condition>Hypoperfusion</condition>
  <condition>Gut Damage</condition>
  <arm_group>
    <arm_group_label>citrulline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>alanine</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Citrulline</intervention_name>
    <description>single dose</description>
    <arm_group_label>citrulline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>alanine</intervention_name>
    <description>single dose</description>
    <arm_group_label>alanine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male

          -  age 18-35 years

        Exclusion Criteria:

          -  not healthy

          -  use of medication or related products

          -  alcohol misuse

          -  smoking
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Maastricht University Medical Center</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <zip>6202 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2010</study_first_submitted>
  <study_first_submitted_qc>November 10, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2010</study_first_posted>
  <last_update_submitted>November 7, 2011</last_update_submitted>
  <last_update_submitted_qc>November 7, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 8, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Maastricht University Medical Center</investigator_affiliation>
    <investigator_full_name>Kim van Wijck</investigator_full_name>
    <investigator_title>MD, PhD student</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

